Clinical trial
Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx…
NCT00123864 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00123864 |
|---|---|
| Title | Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function |
| Official title | A Phase I/II Feasibility Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function |
| Lead sponsor | Alberta Health services, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Nasopharyngeal Neoplasms |
| Intervention type | Procedure |
| Interventions | Intensity-modulated radiation therapy |
| Enrollment | 25 |
| Start date | Jan 1, 2000 |
| First posted | Jul 26, 2005 |
| Last update posted | Feb 9, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: